New thinking about postoperative hypoalbuminemia: A hypothesis of occult protein-losing enteropathy

Open Medicine

Volumn 3, Issue 4, 2009, Pages

  Redelmeier, Donald A ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84855900037     PISSN: None     EISSN: 19112092     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Chang Y, Tsai Y, Lin P, Chen M, Liu C. Prevalence and risk factors for postoperative delirium in a cardiovascular intensive care unit. Am J Crit Care 2008;17(6):567-575.
2. Ryan AM, Hearty A, Prichard RS, Cunningham A, Rowley SP, Reynolds JV. Association of hypoalbuminemia on the first pos- toperative day and complications following esophagectomy. J Gastrointest Surg 2007;11(10):1355-1360.
3. Ueda M, Endo I, Nakashima M, Minami Y, Takeda K, Matsuo K, et al. Prognostic factors after resection of pancreatic cancer. World J Surg 2009;33(1):104-110.
4. Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, et al. The APACHE III prognostic system. Risk pre- diction of hospital mortality for critically ill hospitalized adults. Chest 1991;100(6):1619-1636.
5. Doweiko JP, Nompleggi DJ. The role of albumin in human physi- ology and pathophysiology, Part III: Albumin and disease states. JPEN J Parenter Enteral Nutr 1991;15(4):476-483.
6. Takeda Y, Reeve EB. Studies of the metabolism and distribution of albumin with autologous I131-albumin in healthy men. J Lab Clin Med 1963;61:183-202.
7. Alderson P, Bunn F, Lefebvre C, Li Wan Po A, Li L, Roberts I, et al. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev 2004;Oct 18(4):CD001208.
8. Ruot B, Papet I, Bechereau F, Denis P, Buffiere C, Gimonet J, et al. Increased albumin plasma efflux contributes to hypoalbu- minemia only during early phase of sepsis in rats. Am J Physiol Regul Integr Comp Physiol 2003;284(3):R707-R713.
9. Lee G, Dennis A, editors. Cecil Medicine. Philadelphia: Saunders Elsevier; 2008. p. 1097.
10. Durward A, Mayer A, Skellett S, Taylor D, Hanna S, Tibby SM, et al. Hypoalbuminaemia in critically ill children: incidence, prognosis, and influence on the anion gap. Arch Dis Child 2003;88(5):419-422.
11. Schirmer-Mikalsen K, Vik A, Gisvold SE, Skandsen T, Hynne H, Klepstad P. Severe head injury: control of physiological variables, organ failure and complications in the intensive care unit. Acta Anaesthesiol Scand 2007;51(9):1194-1201.
12. Reinhardt GF, Myscofski JW, Wilkens DB, Dobrin PB, Mangan JE, Stannard RT. Incidence and mortality of hypoalbuminemic patients in hospitalized veterans. JPEN J Parenter Enteral Nutr 1980;4(4):357-359.
13. Small intestine. Wikipedia [website]. Available: http://en.wikipedia.og/wiki/Small_intestine (accessed 2009 Nov 1).
14. Mankertz J, Schulzke J. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications. Curr Opin Gastroenterol 2007;23(4):379-383.
15. Russell JA. Management of sepsis. N Engl J Med 2006;355(16):1699-1713.
16. Fishel RS, Are C, Barbul A. Vessel injury and capillary leak. Crit Care Med 2003;31(8 Suppl):502-511.
17. Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev 2006;86(1):279-367.
18. Aghajanian A, Wittchen ES, Allingham MJ, Garrett TA, Burridge K. Endothelial cell junctions and the regulation of vascular per- meability and leukocyte transmigration. J Thromb Haemost 2008;6(9):1453-1460.
19. Peters T. All about albumin. Amersterdam: Elsevier Inc; 1995.
20. Clayburgh DR, Shen Le, Turner JR. A porous defense: the leaky epithelial barrier in intestinal disease. Lab Invest 2004;84(3):282-291.
21. Griffiths AM, Drobnies A, Soldin SJ, Hamilton JR. Enteric protein loss measured by fecal alpha 1-antitrypsin clear- ance in the assessment of Crohn's disease activity: a study of children and adolescents. J Pediatr Gastroenterol Nutr 1986;5(6):907-911.
22. Schulzke J, Tröger H, Amasheh M. Disorders of intestinal se- cretion and absorption. Best Pract Res Clin Gastroenterol 2009;23(3):395-406.
23. Laine L, Garcia F, McGilligan K, Malinko A, Sinatra FR, Thomas DW. Protein-losing enteropathy and hypoalbuminemia in AIDS. AIDS 1993;7(6):837-840.
24. Bode L, Salvestrini C, Park PW, Li J, Esko JD, Yamaguchi Yu, et al. Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function. J Clin Invest 2008;118(1):229-238.
25. Ma TY, Anderson JM. Tight junctions and the intestinal barrier; In: Johnson LR, editor. Physiology of the gastrointestinal tract. 4th ed. Vol 2. Burlington (MA): Elsevier Academic Press; 2006. p. 1559-1594.
26. Lencer WI. Patching a leaky intestine. N Engl J Med 2008;359(5):526-528.
27. Perel P, Roberts I. Colloids versus crystalloids for fluid resusci- tation in critically ill patients. Cochrane Database Syst Rev 2007;Oct 17(4):CD000567.
28. Liberati A, Moja L, Moschetti I, Gensini GF, Gusinu R. Human albumin solution for resuscitation and volume expansion in crit- ically ill patients. Intern Emerg Med 2006;1(3):243-245.
29. Minson CT, Wladkowski SL, Pawelczyk JA, Kenney WL. Age, splanchnic vasoconstriction, and heat stress during tilting. Am J Physiol 1999;276(1 Pt 2):R203-R212.
30. Cohen DC, Winstanley A, Engledow A, Windsor AC, Skipworth JR. Marathon-induced ischemic colitis: why running is not al- ways good for you. Am J Emerg Med 2009;27(2):e5-e7.
31. Wilkes MM, Navickis RJ. Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med 2001;135(3):149-164.
32. Schultze HE, Heremans JF. Molecular biology of human pro- teins, with special reference to plasma proteins. Amsterdam: Elsevier; 1966.
33. Boutros A. Intra- and postoperative use of albumin. Clinical indications and results. Curr Stud Hematol Blood Transfus 1986;53(53):180-185.
34. Fleck A, Raines G, Hawker F, Trotter J, Wallace PI, Ledingham IM, et al. Increased vascular permeability: a major cause of hypoalbu- minaemia in disease and injury. Lancet 1985;1(8432):781-784.
35. Hoye RC, Bennett SH, Geelhoed GW, Gorschboth C. Fluid vol- ume and albumin kinetics occurring with major surgery. JAMA 1972;222(10):1255-1261.
36. Yedgar S, Carew TE, Pittman RC, Beltz WF, Steinberg D. Tis- sue sites of catabolism of albumin in rabbits. Am J Physiol 1983;244(1):E101-E107.
37. Nicholson JP, Wolmarans MR, Park GR. The role of albumin in critical illness. Br J Anaesth 2000;85(4):599-610.
38. Rothschild MA, Oratz M, Schreiber SS. Extravascular albumin. N Engl J Med 1979;301(9):497-498.
39. Golub R, Sorrento JJ, Cantu R, Nierman DM, Moideen A, Stein HD. Efficacy of albumin supplementation in the surgical inten- sive care unit: a prospective, randomized study. Crit Care Med 1994;22(4):613-619.
40. Foley EF, Borlase BC, Dzik WH, Bistrian BR, Benotti PN. Albumin supplementation in the critically ill. A prospective, randomized trial. Arch Surg 1990;125(6):739-742.
41. Brown RO, Bradley JE, Bekemeyer WB, Luther RW. Effect of al- bumin supplementation during parenteral nutrition on hospital morbidity. Crit Care Med 1988;16(12):1177-1182.
42. Karbach U, Ewe K, Bodenstein H. Alpha 1-antitrypsin, a reliable endogenous marker for intestinal protein loss and its application in patients with Crohn's disease. Gut 1983;24(8):718-723.
43. Chiu NT, Lee BF, Hwang SJ, Chang JM, Liu GC, Yu HS. Protein- losing enteropathy: diagnosis with (99m)Tc-labeled human serum albumin scintigraphy. Radiology 2001;219(1):86-90.
44. Villela NR, Vázques BYS, Intaglietta M. Microcirculatory ef- fects of intravenous fluids in critical illness: plasma expan- sion beyond crystalloids and colloids. Curr Opin Anaesthesiol 2009;22(2):163-167.
45. Soeters PB. Rationale for albumin infusions. Curr Opin Clin Nutr Metab Care 2009;12(3):258-264.